Hiroyuki Ueno
Directeur/Membre du Conseil chez Alphanavi Pharma KK
Postes actifs de Hiroyuki Ueno
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Kyoto University Innovation Capital Co., Ltd.
 Kyoto University Innovation Capital Co., Ltd. Investment ManagersFinance Kyoto University Innovation Capital Co., Ltd. (KYOTO-iCAP) is a Venture Capital firm, a subsidiary of Kyoto University founded in 2014. Kyoto University Innovation Capital Co., Ltd. is headquartered in Kyoto. | Private Equity Investor | 01/10/2020 | - |
Alphanavi Pharma KK
 Alphanavi Pharma KK Pharmaceuticals: MajorHealth Technology Alphanavi Pharma KK is a pharmaceutical company based in Kyoto, Japan that focuses on developing new treatments for chronic pain. The Japanese company's goal is to alleviate discomfort and bring smiles back to patients and their families. The company was founded in 2019 by Yoshihiro Koyamada. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Hiroyuki Ueno
Anciens postes connus de Hiroyuki Ueno
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CHORDIA THERAPEUTICS INC. | Directeur/Membre du Conseil | - | - |
Statistiques
Internationale
| Japon | 4 |
Opérationnelle
| Director/Board Member | 2 |
| Private Equity Investor | 1 |
Sectorielle
| Health Technology | 3 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CHORDIA THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Kyoto University Innovation Capital Co., Ltd.
Kyoto University Innovation Capital Co., Ltd. Investment ManagersFinance Kyoto University Innovation Capital Co., Ltd. (KYOTO-iCAP) is a Venture Capital firm, a subsidiary of Kyoto University founded in 2014. Kyoto University Innovation Capital Co., Ltd. is headquartered in Kyoto. | Finance |
Alphanavi Pharma KK
Alphanavi Pharma KK Pharmaceuticals: MajorHealth Technology Alphanavi Pharma KK is a pharmaceutical company based in Kyoto, Japan that focuses on developing new treatments for chronic pain. The Japanese company's goal is to alleviate discomfort and bring smiles back to patients and their families. The company was founded in 2019 by Yoshihiro Koyamada. | Health Technology |
- Bourse
- Insiders
- Hiroyuki Ueno
- Expérience
